Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FDA grants avatrombopag Orphan Drug Designation for the treatment of Chemotherapy-Induced Thrombocytopenia

Dova Pharmaceuticals, Inc., a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™) has been granted Orphan Drug Designation[1] (ODD) by the US Food and Drug Administration (FDA) for avatrombopag for the potential treament of Chemotherapy-Induced Thrombocytopenia (CIT). Enrollment remains ongoing for the phase 3 clinical study for the treatment of patients with CIT.  CIT, a potentially serious complication of chemotherapy, results in low platelet levels and can lead to chemotherapy dose reductions, chemotherapy dose delays, or changes to chemotherapy regimens. For cancer

BraineHealth Launches a Free Medipacker Academy Program — Enabling Backpackers to Give First Aid to People in Need.

BraineHealth launches Medipacker Academy — a four-stage free online education program that enables backpackers to provide first aid wherever they are.[Medipacker - Altruistic Traveling] Stockholm, December 21, 2019 — The Swedish company BraineHealth that is developing automation tools for healthcare using AI methods launched a free humanitarian Medipacker education program. Medipacker Academy is a partly free online four-stage program for backpackers that, once completed, makes them qualified to provide first aid to those in need. Medipacker Academy program stages are Aspirant,

Nordic Capital to acquire Consilium Marine & Safety, a leading supplier of fire & gas safety products and solutions that protect people, material values and the environment

Nordic Capital has signed an agreement to acquire the business unit Consilium Marine & Safety, one of the world’s largest producers of safety and safety-related technologies, within fire and gas detection, for the marine, oil and gas, transport and building sectors, from Consilium AB (publ) for an enterprise value of SEK 3 000 million on a cash and debt free basis. In partnership with the management team, Nordic Capital will support Consilium Marine & Safety’s continued growth as a strong new independent company and further strengthen the Company’s strong position and service offering by

EQT to sell Clinical Innovations

· EQT Mid Market US and EQT Mid Market Asia III to sell Clinical Innovations, a leading global provider of medical devices for Labor & Delivery and Neonatal Intensive Care, to LABORIE for an Enterprise Value of USD 525m · During EQT’s ownership, Clinical Innovations has successfully transitioned from a distributor sales model to a direct sales force in select key markets, broadened its product portfolio in the Neonatal Intensive Care segment through product acquisitions and established a foothold in China  The EQT Mid Market US fund and the EQT Mid Market Asia III fund (jointly “

SDRL – Seadrill Limited Announces Contract Award for the West Phoenix

Hamilton, Bermuda, December 20, 2019 - Seadrill Limited (“Seadrill”) has secured a multiple well contract with Vår Energy AS for the West Phoenix for work on the Balder re-development project in Norway. Total contract value for the firm portion of the contract is expected to be approximately $302 million with commencement expected at the end of 2Q 2021 and running through 3Q 2023. In addition to the base rate a well based performance bonus mechanism is included in the award giving potential for incremental revenue.  The contract is subject to authority approval of the Balder Future plan for

Nel ASA: Receives purchase order for two H2Station® units for Europe

(Oslo, 20 December 2019) Nel Hydrogen A/S, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order for the delivery of two H2Station® units for fueling of vehicles in Europe. “We’re happy our hydrogen fueling station solutions are continuing to support Europe’s hydrogen infrastructure deployment,” says Jens Egholt Rasmussen, Global Sales Director for Nel Hydrogen Fueling. The contract value is approximately EUR 2 million. The customer has requested to remain unnamed, and further details will be released in Q1-2020. ENDS For additional information, please contact:

Höegh LNG : Mandatory notification of trade

Hamilton, Bermuda, 20 December 2019 - Höegh LNG Holdings Ltd. ("Höegh LNG") advises that Ragnar Wisløff, Head of Change and Transformation and primary insider, on Friday 20 December 2019 sold 1,514 common units in Höegh LNG Partners LP (“HMLP”) and his related party Fri Agenda AS sold 5,178 common units in HMLP, both at a unit price of USD 15.71. Following the above transactions, Ragnar Wisløff owns 178,800 stock options in Höegh LNG and 2,667 phantom units in HMLP. His related party Fri Agenda AS owns 23,934 shares in Höegh LNG.   * * *

Exercise of over-allotment option in relation to the IPO of Optomed Plc and termination of the stabilisation period

OPTOMED PLC          STOCK EXCHANGE RELEASE                      20 December 2019 at 8 p.m. Exercise of over-allotment option in relation to the IPO of Optomed Plc and termination of the stabilisation period NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL With reference to the prospectus

Results of the Extraordinary General Meeting of Nustay A/S

Today, on December 20, 2019, an Extraordinary General Meeting was held of Nustay A/S. Below follows a summary of the resolutions made. All resolutions were made with the required majority.Chantal Pernille Patel was elected the chairman of the general meeting.  Item 1: Election of members to the board of directors The general meeting decided to elect Christian Strøjer and Mathias Lundø Nielsen to the board of directors. Item 2: Authorisations to the board of directors to increase the share capital of the Company The board of directors had proposed a number of resolutions to the

EAB GROUP PLC: ACQUISITION OF OWN SHARES 20.12.2019

EAB GROUP PLC NOTIFICATION 20.12.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 20.12.2019   Date 20.12.2019  Exchange transaction Buy  Share class EAB  Amount 480  Average price/share 2.3200 EURHighest price/share 2.3200 EURLowest price/share 2.3200 EURTotal price 1,113.60 EUR      The shares held by EAB Group Plc on 20.12.2019:   EAB 6,946     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.12.2019

Fiskars Corporation NOTIFICATION 20.12.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.12.2019   Date 20.12.2019  Exchange transaction Buy  Share class FSKRS  Amount       1,000  Average price/share 11.3250 EURHighest price/share 11.3400 EURLowest price/share 11.3000 EURTotal price 11,325.00 EUR      The shares held by Fiskars Corporation on 20.12.2019:   FSKRS  405,677     On behalf of Fiskars Corporation

Positive Top-line results from Phase I/II trial with intralymphatic Diamyd[®]

Diamyd Medical announced today, when all 12 patients have been followed throughout the 30-month period in the open-label trial DIAGNODE-1, that the patients show on average a positive clinical course with a near normal long-term blood sugar and a low need for externally supplied insulin. The three patients who received an extra Diamyd[®] injection into the lymph node after their 30-month visit showed a maintained own insulin production between the 30- and 43-month visits, as well as lower long-term blood sugar and insulin requirements compared to baseline. Safety looks good and no serious

Bambuser AB (publ): Change of Certified Advisor

Bambuser AB (publ) has entered into an agreement with Svensk Kapitalmarknadsgranskning AB (SKMG) regarding the service as a Certified Advisor. SKMG will take over as Certified Advisor on January 1, 2020. Until then, Västra Hamnen Corporate Finance AB will continue to act as Certified Advisor for the company. Contact information Maryam Ghahremani, CEO | tel: + 46 708 720 266 | e-mail: maryam@bambuser.com or visit bambuser.com/ir Certified Advisor Västra Hamnen Corporate Finance AB | tel: +46 40-20 02 50 | e-mail: ca@vhcorp.se About Bambuser AB Bambuser was founded in

DNB ASA - Share buy-back status after week 51

During week 51 2019, DNB ASA has purchased 1 179 000 own shares at an average price of NOK 159.11 per share. After this, DNB ASA owns a total of 9 429 000 own shares. The repurchase of shares is part of the share buy-back programme announced by DNB ASA on 24 October 2019, as subsequently amended by an announcement on 20 November and 12 December 2019. The share buy-back programme comprises up to approximately 23.7 million shares, of which up to approximately 15.6 million shares may be repurchased in the open market. The rest will be redeemed from the state of Norway on a proportionate

Kværner ASA: Mandatory notification of trade primary insiders

Mandatory notification of trade primary insiders 20 December 2019 - The following primary insider has purchased shares in Kværner ASA: Idar Eikrem, EVP & CFO in Kværner ASA through a private company has today Friday 20 December 2019 purchased 40 000 shares in Kværner ASA at a price of NOK 10,75.Following the transaction, Idar Eikrem holds 180 329 shares in Kværner ASA, this including shareholding owned through a private company . ENDSInvestor Relations: Idar Eikrem, EVP & CFO, Kvaerner, Mob: +47 950 28 363, email: ir@kvaerner.com  Insider trading officer: Henrik Indaomi, SVP

myFC to showcase fuel cell battery hybrid concept for the automotive sector in June 2020

myFC is reinforcing its commitment to the automotive sector, aiming to be a part of the energy supply solution through its scalable, modular fuel cell technology.Swedish fuel cell company myFC began exploring automotive applications for its scalable, modular fuel cell technology in 2017. The work to develop the technology, separately and in partnerships, has continued since. A first prototype was shown in 2018, and the company now commits to showcasing a fully functional fuel cell battery hybrid concept to stakeholders and the wider public in the middle of 2020. The intention with

Invitation to tender – Frame agreements for Consultancy services

Freyr intend to enter into framework agreements for purchasing of consultancy services for several disciplines with one or more companies.Freyr is working with three parallel projects and the purchase of services will include the concept engineering phase and pre-engineering phase. 1. 32 GWh Giga Factory at Stormoen. Greenfield area 2. 2 GWh pilot factory at Mo Industripark. Brownfield area 3. On shore wind farm, 600 MW, at Sjonfjellet The request documents : will be available by contacting Freyr at following email address: procurement@freyrbattery.com Subject: Framework

First patient treatments delivered with RayStation and Hitachi proton therapy system at Sibely Memorial Hospital

Treatment planning system RayStation® from RaySearch has been used together with Hitachi’s latest proton therapy system to treat cancer patients at the newly opened John Hopkins Proton Center at Sibley Memorial Hospital in Washington, DC, USA.The 80,000 square-foot facility, which opened October 1, houses cutting-edge proton therapy equipment from Hitachi alongside next-generation treatment planning software from RaySearch. Three rotating gantry treatment rooms and one fixed-beam research room at the center are equipped with a full suite of digital technologies for effective proton therapy

Repurchase of shares in Nobina

During 19 December 2019, Nobina AB (publ) (“Nobina”) repurchased a total of 27,960 Nobina shares within the framework of the repurchase programme introduced by the Board of Directors to meet the requirements arising under Nobina’s Share Saving Scheme, meaning securing the delivery of Performance Shares to the participants and securing and covering the costs for any social security contributions that may arise. The repurchase programme, which Nobina announced on 29 October 2019, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission

Hospice inpatient unit set to reopen by May as new doctors join team and virtual consultants go live

Cheers, tears and applause as announcement is made to staffTHE inpatient unit of a rural hospice which was closed earlier this year due to a shortage of staff is set to reopen by May 2020. Bosses at St Mary’s Hospice have managed to recruit the speciality doctors they need to work alongside existing members of the team. They will be supported from afar by a bank of digital consultants who are specialists in palliative care. The news was announced to staff of the hospice today by chief executive Val Stangoe, who said: “There were cheers, tears and applause. It was such a nice way to

#19-1177 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB       About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete

Correction pressrelease: Last day for trading with BTA in Heliospectra AB (publ)

Correction of pressrelease. The release was not supposed to include a reference to Market Abuse Regulation (MAR) which is now taken away below.  The last day for trading in the company's paid subscribed shares, HELIO BTA, is December 30, 2019. Information about paid subscribed shares:Short name: HELIO BTAISIN Code: SE0013460771Last day of trading: December 30, 2019Financial and legal advisors Västra Hamnen Corporate Finance AB is a financial advisor and MAQS Advokatbyrå is legal advisor to Heliospectra in connection with the rights issue. For further information, please

BRAbank ASA: BRA-ME – Establishment of underwriting syndicate for private placement and Tier2 bond issue. Company update.

Bergen, 20 December 2019: The Board of Directors of BRAbank ASA ("BRAbank" or the "Company") intends to conduct a private placement of NOK 65-85 million at a subscription price of NOK 0.5 per share (the "Private Placement") to strengthen the Company's capital adequacy. The Private Placement has been underwritten with NOK 65 million by certain large existing shareholders in the Company. Moreover, the Board of Directors intends to conduct an issuance of a Tier 2 bond loan in the amount of up to NOK 35 million, of which NOK 15 million has been underwritten by certain large existing

News update – start-up preparations initiated at verification project in Ouarzazate

Ongoing installations at Azelio’s verification project in Ouarzazate, Morocco are progressing rapidly. All mechanical components have now been installed and Azelio’s installation team is currently working to ensure the system functions as expected. The critical stages of site preparation and installation of the system’s power unit have now been completed. The verification project is currently in the phase of commissioning and start-up preparations are progressing according to plan.“I’m proud of the execution and commitment from Azelio’s installation team and all other parties whom are

There are no items matching the current filter
There are no more items matching the current filter
Back to top